New drug aims to shield kidneys during risky heart operations
NCT ID NCT06168799
Summary
This study tested whether a drug called ilofotase alfa could prevent or reduce kidney damage in patients undergoing major open heart surgery. It involved 271 adults with pre-existing reduced kidney function who were at high risk for further injury. Patients received either the study drug or a placebo (inactive substance) just before and after their surgery to see if it helped protect their kidneys.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPEN HEART SURGERY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research site
Munich, Germany
Conditions
Explore the condition pages connected to this study.